Drug shortages demand attention and collaboration from all stakeholders involved in providing life-saving medicines to patients. Innovative biopharmaceutical companies have extensive measures in place to help prevent and mitigate potential drug shortages, including risk management systems. Manufacturers are the U.S. Food and Drug Administration’s (FDA) source for most drug shortage information. The agency works closely with biopharmaceutical companies to prevent or reduce the impact of shortages.